Rheumatoid arthritis-related interstitial lung disease (RA-ILD): a possible association between disease activity and prognosis


Por: Rojas-Serrano, Jorge, Mejia, Mayra, Rivera-Matias, Pedro A., Herrera-Bringas, Denisse, Perez-Roman, I, Diana, Perez-Dorame, Renzo, Mateos-Toledo, Heidegger

Publicada: 1 jun 2022
Resumen:
Objectives We hypothesized that RA disease activity might be associated with the survival of RA-ILD patients. To evaluate this possibility, we analyzed data on disease activity during follow-up in an RA-ILD cohort and compared disease activity between surviving patients and those who died during follow-up. Methods RA-ILD patients referred for medical evaluation and treatment at a single center, with CDAI scores during all follow up were included. We estimated the HR of the mean of the CDAI score during follow-up with survival. Also, we compared the survival function of patients with high disease activity (CDAI scores >= 22) during all follow-up with those with moderate and low disease activity. Results Thirty-seven patients were included. The mean of the CDAI score during follow-up was higher in death patients (median 30.8 +/- 18.5 Vs. 16.8 +/- 11.3), and a single unit increase in the mean of the CDAI score was associated with non-survival, HR:1.07 (95% CI: 1.02 -1.12). Patients with high disease activity during all follow-up (CDAI scores > 22) had lower survival function in comparison with moderate and low disease activity (P = 0.042). Conclusion The results of the study suggest that higher RA disease activity is associated with a worse prognosis of RA-ILD patients. The hypothesis that high disease activity is associated with worse survival in RA-ILD patients must be evaluated in more extensive cohort studies and clinical trials.

Filiaciones:
Rojas-Serrano, Jorge:
 Perez-Roman, Diana, I , Inst Nacl Enfermedades Resp, Interstitial Lung Dis & Rheumatol Unit, Calzada Tlalpan 4502,Secc 16, Mexico City 14080, DF, Mexico

 Univ Nacl Autonoma Mexico, Fac Med, Programa Maestria & Doctorado Ciencias Med, Coyoacan, Mexico

Mejia, Mayra:
 Perez-Roman, Diana, I , Inst Nacl Enfermedades Resp, Interstitial Lung Dis & Rheumatol Unit, Calzada Tlalpan 4502,Secc 16, Mexico City 14080, DF, Mexico

Rivera-Matias, Pedro A.:
 Perez-Roman, Diana, I , Inst Nacl Enfermedades Resp, Interstitial Lung Dis & Rheumatol Unit, Calzada Tlalpan 4502,Secc 16, Mexico City 14080, DF, Mexico

Herrera-Bringas, Denisse:
 Perez-Roman, Diana, I , Inst Nacl Enfermedades Resp, Interstitial Lung Dis & Rheumatol Unit, Calzada Tlalpan 4502,Secc 16, Mexico City 14080, DF, Mexico

Perez-Dorame, Renzo:
 Perez-Roman, Diana, I , Inst Nacl Enfermedades Resp, Interstitial Lung Dis & Rheumatol Unit, Calzada Tlalpan 4502,Secc 16, Mexico City 14080, DF, Mexico

Mateos-Toledo, Heidegger:
 Perez-Roman, Diana, I , Inst Nacl Enfermedades Resp, Interstitial Lung Dis & Rheumatol Unit, Calzada Tlalpan 4502,Secc 16, Mexico City 14080, DF, Mexico
ISSN: 07703198





Clinical Rheumatology
Editorial
Springer London, 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 41 Número: 6
Páginas: 1741-1747
WOS Id: 000749955700002
ID de PubMed: 35112192